TransCode Therapeutics Inc. (NASDAQ:RNAZ) jumped over 15% but was down 37% in the past month. The company has priced its initial public offering of 6.25 million common shares at an offering price of $4 per share. TransCode expects gross proceeds of $25 million before accounting for offering expenses and subtracting underwriting commissions and discounts. Equally, …
TransCode Therapeutics Inc (NASDAQ:RNAZ)
TransCode Therapeutics Inc (NASDAQ:RNAZ) Stock Continues to Fall: Down 36% in a Week
The RNA oncology firm TransCode Therapeutics Inc (NASDAQ:RNAZ) has not had a great time in recent days as far as its stock performance is concerned. On Wednesday, the stock suffered from another selloff and went down by 16% to takes its losses for the week to 36%. Earlier on this week the company completed its …